Onconova Therapeutics Announces Upcoming Presentation at the 3rd Annual RAS Targeted Drug Development Summit

NEXT STORY
This Magic Mushroom Day, Communities Across the Globe Celebrate the Transformative Healing Power of Using Psychedelics as Medicine
PREV STORY
OSE Immunotherapeutics Presented Positive Final Results of Tedopi® Phase 3 Clinical Trial in Secondary Resistant Non-Small Cell Lung Cancer Patients at the European Society for Medical Oncology (ESMO) Virtual Congress 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering

author_avatar
NASDAQ Market News

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Amolyt Pharma to Host Key Opinion Leader Webinar and Discuss Results of Phase I Clinical Trial of AZP-3601 on Friday, October 1st at 10:00am ET

author_avatar
NASDAQ Market News